Sclerotherapy in the treatment of infantile haemangioma: a case series in the treatment of 250 infants

This research paper presents clinical and clinical-functional examination and treatment data of 250 children with congenital vascular malformations (haemangiomas), aged less than 5 years, from 2018 to 2023. It is worth noting that Of the total number of patients with congenital haemangiomas, boys were 75 (40%) and girls were 1.5 times more - 175 (60%). Obviously, most of the patients with congenital haemangiomas were children under 3 years of age. A part of patients with haemangiomas (14 people - 22.4%) before admission to the clinic received preliminary treatment including X-ray therapy, hormone therapy and surgical treatment, which turned out to be ineffective. The size of vascular masses varied from small to large in area and different in shape. Most of the masses had a regular rounded shape. A smaller part of the sample (6%) were large defects up to 6 cm2 and a larger part were defects up to 1 cm2 (64%). Among the observed patients, non-resident patients (41-65%) predominated, who mostly had defects up to 3 cm2 (30%), 38.4% had combined lesions of several anatomical areas. In 24 patients (38.4%) there was a combined lesion of several different anatomical areas, which significantly complicated the treatment, but was not a contraindication to its performance. This study shows practical experience based on the use of alternative modern methods of treatment, which is extremely relevant in a situation where the number of patients with this malformation is increasing every year, especially among children. The aim of the study is to acquaint the general public of scientists to the study of this issue, as well as to familiarise with our practical experience, which, as we believe, makes a certain contribution to the development of medical sciences, namely in the treatment of hemangiomas.